In-Gel Tryptic Digestion and HCD/EThcD LC-MS/MS for Mapping Autophosphorylation Sites
This protocol describes a targeted workflow for identifying and quantitatively comparing kinase autophosphorylation sites, using in-gel proteolytic digestion, LC-MS/MS analysis, phosphosite localisation, and extracted ion chromatogram (XIC) analysis. The detailed protocol begins with an excised SDS-PAGE gel band containing the immunoprecipitated kinase of interest. Standard cell culture, expression, immunoprecipitation, and SDS-PAGE procedures can be used to generate this starting material according to the experimental system under investigation; the specific conditions used for NEK1 are described in our associated research article. Here, the protocol is applied to characterise phosphorylation sites on NEK1—a serine/threonine kinase implicated in amyotrophic lateral sclerosis (ALS)—using a homozygous NEK1 knockout cell background in which GFP-tagged wild-type or kinase-dead NEK1 constructs are re-expressed. This experimental system enables accurate assessment of kinase-dependent phosphorylation events in the absence of endogenous NEK1. A key methodological feature of the workflow is the use of two parallel MS2 fragmentation strategies: higher energy collisional dissociation (HCD) and electron-transfer/HCD (EThcD). EThcD generates complementary b/y and c/z ion series, providing superior localisation confidence for labile phosphorylation events that are difficult to resolve using HCD alone. Relative phosphopeptide abundance across conditions can be assessed using extracted ion chromatograms generated in FreeStyle, or using Skyline software with normalisation to the total ion current (TIC), as performed in the associated NEK1 study. Although demonstrated here using NEK1, the protocol is readily adaptable to other kinases amenable to immunoprecipitation and will be of interest to researchers studying kinase signalling, post-translational modification biology, and disease-associated phosphorylation events.
Suspension-Based Intracellular Immunofluorescence Staining Coupled With Genome-Wide CRISPR-Cas9 Screening to Identify Regulators of O-GlcNAcylation
Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that regulates diverse cellular processes, including transcription, signal transduction, metabolism, and cell fate determination. Systematic identification of genes that modulate global O-GlcNAc levels remains technically challenging at the genome scale. Here, we describe a pooled CRISPR-Cas9 screening protocol that combines the human genome-scale CRISPR knockout (GeCKO) v2 knockout library with intracellular immunofluorescence staining using the anti-O-GlcNAc antibody RL2 and fluorescence-activated cell sorting (FACS). In this workflow, HEK293T cells are transduced with the GeCKO v2 lentiviral library at a low multiplicity of infection to ensure predominantly single-sgRNA integration. Following puromycin selection, cells are fixed, permeabilized, and stained in suspension with RL2. The top 5% of cells with the highest intracellular RL2 fluorescence are collected as the RL2-high population, while a corresponding unsorted/input sample is retained as the reference for downstream sgRNA enrichment analysis. Genomic DNA is recovered from the RL2-high and unsorted/input samples, and integrated sgRNA cassettes are amplified through a two-step PCR and library-preparation workflow for Illumina sequencing. This protocol enables the identification of candidate genes whose knockout is associated with increased intracellular RL2 fluorescence.
Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo
Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states.
Monitoring Protein Secretion in Living Cells With a HiBiT-Integrated RUSH System
The cellular secretory pathway is a fundamental physiological process; however, precise, efficient, and quantitative methods for monitoring this process remain rarely explored. Although several classic approaches have been developed to investigate secretory trafficking, the RUSH (Retention Using Selective Hooks) system currently represents the most advanced technique. Here, we introduce a method termed the HiBiT-integrated RUSH system and provide a detailed protocol for its application. This approach enables real-time monitoring of the secretion of cell membrane receptors such as ACE2, PDL1, NTCP, and CD209. By converting the cellular secretion process into a quantitative curve, our method offers an objective means for result interpretation. The HiBiT-integrated RUSH system is particularly effective for studying the transport dynamics of various cell membrane receptors, thereby facilitating the identification of both common and specific regulators of the cellular secretory pathway.
Preparation of Phosphoinositide-Containing Supported Lipid Bilayers and Quantitative Assessment of Protein Recruitment to Membrane Surfaces
Small GTPases and many other peripheral membrane proteins regulate essential cellular processes through dynamic interactions with cellular membranes. These interactions are often controlled by membrane composition, particularly phosphoinositides (PIPs), which modulate the recruitment of GTPases, their regulators, and their effectors. Quantitative characterization of protein recruitment to defined membrane environments remains technically challenging. Here, we describe a protocol for preparing supported lipid bilayers (SLBs) containing defined phosphoinositide compositions in polydimethylsiloxane (PDMS) chambers and monitoring protein recruitment by total internal reflection fluorescence (TIRF) microscopy. Purified fluorescently labeled proteins are incubated with SLBs to measure membrane association in real time under controlled biochemical conditions. The method enables quantitative analysis of membrane recruitment kinetics and comparison of protein binding across different lipid compositions or in the presence of partner proteins. Combining the biochemical precision of a reconstituted membrane system with the sensitivity of TIRF imaging, this protocol provides a robust and versatile platform for studying lipid-dependent membrane recruitment. Although developed to investigate small GTPase signaling, it is readily applicable to a wide range of peripheral membrane proteins and membrane-associated signaling mechanisms.
An Optimized Protocol for TurboID-Based Proximity Labeling and Sample Preparation for Mass Spectrometry in Arabidopsis thaliana
Plant proximity labeling proteomics enables the identification of transient and weak intracellular protein interactions that are undetectable via traditional biochemical assays. Conventional enrichment pipelines suffer severe quantitative bias caused by urea-derived chemical artifacts and high mass spectrometry background signals from sample- and carrier-derived impurities. This protocol describes a complete standardized workflow for biotinylated protein extraction, enrichment, and LC-MS/MS sample preparation optimized for Arabidopsis seedlings. The procedure integrates controlled urea dilution and pre-desalting to suppress non-enzymatic protein modifications, introduces acetylation blocking of streptavidin magnetic beads to mitigate streptavidin degradation during on-bead digestion, and applies two-step on-bead trypsin digestion to improve peptide coverage. Multi-point sample retention and dual protein quantification are implemented throughout all experimental stages to ensure full-process quality control. Subsequent data processing pipelines using Spectronaut for data-independent acquisition (DIA) data and MaxQuant for data-dependent acquisition (DDA) data are also detailed for consistent proteome quantification. This workflow delivers higher protein recovery and better signal-to-noise ratios than standard protocols while offering flexible adaptation for various crop proximity labeling and affinity enrichment proteomic research.
Identifying Differentially Expressed Proteins via Plasma Exosomal Proteomics
Extracellular vesicle (EV) proteomics can be used to study intercellular communication and find biomarkers of non-invasive diseases. Traditional separation methods (ultracentrifugation, size exclusion chromatography) and data-dependent acquisition (DDA) mass spectrometry usually have the drawbacks of copurification of pollutants, poor reproducibility, and insufficient sampling of low-abundance peptides. This protocol describes a workflow for label-free extracellular vesicle proteomics, which combines size exclusion chromatography for vesicle separation, data-independent acquisition (DIA) for deep discovery, and parallel reaction monitoring (PRM) for targeted verification. Plasma-derived extracellular vesicles are treated by standardized lysis, digestion, and LC-MS/MS procedures, so that the protein group of extracellular vesicles can be identified and quantified robustly. The main advantages of this scheme are that it can achieve high quantitative reproducibility, unbiased detection of low-intensity peptides, and seamless transition from discovery to targeted verification, while also being suitable for liquid biopsy samples and various cardiovascular diseases.
Step-by-Step Protocol for Fluorescence-Based Analysis of Uptake in Transporter-Expressing Xenopus laevis Oocytes
Xenopus laevis oocytes are widely used as a heterologous expression system for investigating the function of membrane proteins due to robust expression of heterologous protein and a low endogenous transport background. Traditionally, transporter activity in oocytes has been assessed using electrophysiology or radiolabeled uptake assays, approaches that are constrained by the requirement for electrogenicity of the transport process, availability of radiolabeled compounds, and instrumentation. Here, we describe a fluorescence-based uptake assay that enables direct and rapid quantification of transporter activity using a fluorescence plate reader. The protocol uses the Arabidopsis thaliana sucrose transporter 1 (SUC1) and its fluorescent substrate esculin as a case for how to set up the assay. The workflow includes optimizing assay conditions, sample preparation, fluorescent measurements, and downstream data analysis using R. This method can readily be adapted to other transporter-substrate pairs, and it supports applications such as transporter inhibitor screening, mutational analysis, characterization of kinetic properties, or indirect substrate specificity testing through competition assays. Overall, this protocol provides a simple and scalable alternative to traditional techniques, eliminating the need for radiolabeled compounds or electrophysiology while enabling easy quantitative assessment of transporter activity.
Quantification of 20-Hydroxyecdysone From Drosophila Larvae at the Onset of Metamorphosis
Metamorphosis in class Insecta is defined as the drastic transition of an organism from a larval stage to a morphologically very different adult form. Insects such as Drosophila melanogaster undergo metamorphosis, which requires precise temporal control, exerted by ecdysteroids, the primary regulators of these developmental transitions. The active form of ecdysone is 20-hydroxyecdysone (20E), which acts in pulses that trigger the onset of different developmental stages. A massive pulse of 20E occurs between the prepupal and pupal stages, triggering pupariation. Precise quantification of 20E levels is critical for understanding how this hormonal signaling governs the developmental timing of different stages. This protocol is sensitive for detecting low levels of 20E and describes a methanol-based extraction method coupled with a competitive ELISA to quantify whole-body 20E levels in third-instar Drosophila larvae. Further, this protocol enables detection of differences in ecdysone titers among genotypes affecting ecdysone biosynthesis, particularly at the late third-instar larval stage. This protocol can also be utilized for disease-causing insects (Aedes aegypti), as well as economically relevant beneficial insects (Apis mellifera), to study the effects of ecdysteroid analogs during development.
Immune-Complex-Based In Vitro Deubiquitination Assay
Deubiquitinases (DUBs) are attractive therapeutic targets within the ubiquitin-proteasome system, in part because four of the five DUB subfamilies are cysteine proteases amenable to the development of potent, selective inhibitors, as recently demonstrated for USP7. Identifying DUBs that deubiquitylate and stabilize specific human oncogenic proteins is therefore a promising approach to discovering new mechanism-based targets for cancer therapy. Several complementary experimental strategies are typically required to identify bona fide DUB–substrate pairs. Here, we present an efficient, straightforward in vitro immune-complex protocol to validate USP17-mediated deubiquitylation of the transcriptional co-activator β-catenin. In this assay, both β-catenin and USP17 are immunopurified from transiently transfected 293T cells and then combined to assess USP17 enzymatic activity. The protocol describes the in vitro enzymatic assay performed on immunopurified complexes and the immunoblot-based readout. It can be readily adapted to other DUBs and substrates for mechanistic studies.
A SPAAC-Based Bioorthogonal Method for Verifying Protein Palmitoylation
Palmitoylation is a crucial post-translational modification, and bioorthogonal chemistry based on azide-alkyne cycloaddition is typically used to verify protein palmitoylation. Traditional copper-catalyzed click chemistry (CuAAC) proceeds with fast kinetics and is widely used, but it requires a copper catalyst and suffers from copper-induced toxicity and nonspecific labeling. By contrast, strain-promoted click chemistry (SPAAC) has slower kinetics but is catalyst-free, offering high specificity, low cytotoxicity, and simple operation. However, SPAAC is mostly applied to live-cell labeling and imaging of known palmitoylated proteins in the field of palmitoylation, and its use in identifying novel palmitoylated proteins is still limited. Here, we present a SPAAC-based method for detecting endogenous protein palmitoylation. Compared with CuAAC, this method eliminates the need for copper catalysts and reducing agents, thereby simplifying the procedure and reducing reagent usage.
Proximity Labeling in Caenorhabditis elegans to Detect Neuronal Proteins During Memory Formation
Memory is a fundamental process, regulated by protein–protein interactions within neuronal proteome networks. Learning-dependent changes in specific brain regions important for memory have been detected by mass spectrometry, by comparing proteins from animals trained to learn with mock-trained controls. Detection through this method relies on relative protein abundance; brain dissection is readily available for macroscopic animals to spatially control protein identification by mass spectrometry. In the nematode C. elegans, however, such spatial control is limited due to its microscopic size, hindering its utilization in proteomics. A protocol to address this limitation would strengthen an already excellent model to study memory, given that many proteins for learning are evolutionarily conserved in the worm and single-cell expression is uniquely defined across all 302 neurons. We modified existing protocols to enable (i) proximity labeling detection of neuronal proteins in C. elegans and (ii) high-throughput enrichment of these proteins from >3,000 whole worm bodies simultaneously, to assess trained vs. mock-trained proteomes. This involved the biotin ligase enzyme TurboID, which promiscuously labels nearby proteins with its substrate biotin. Enzyme expression was transgenically restricted to the nervous system, and biotin supplementation was limited to the training (or mock training) period in a classical (gustatory) conditioning paradigm. Labeled proteins were enriched by pull-down using streptavidin, which has a high binding affinity to biotin, and then processed for mass spectrometry runs and qualitative data analysis. This protocol is uniquely advantageous in that it minimizes proteins present before a temporal window of interest (training/mock training), improving the detection of lowly abundant proteins from a specific tissue in the worm (neurons). We have demonstrated that the protocol can sufficiently detect novel learning regulators, thus providing a useful framework to interrogate proteomes in microscopic brains.
How to Perform a Tracer Displacement BRET Assay for the TRPML1 Ion Channel
The transient receptor mucolipin subtype 1 (TRPML1) is a ubiquitously expressed ion channel involved in lysosomal homeostasis. Recent pharmaceutical interest in developing agonist ligands has emerged due to beneficial effects in neurodegenerative diseases. The major high-throughput screening techniques to investigate this ion channel involve fluorescent calcium imaging and electrophysiology. Despite their high capacity for screening compounds, it is well known that both methods face hurdles, such as the need for expensive, specialized equipment. Here, we present a novel technique to screen for ligands of TRPML1 using a bioluminescence resonance energy transfer (BRET) assay. This assay consists of a target engagement assay in live cells, which permits the determination of binding constants between ligands and the target of interest in equilibrium or time-dependently. We employ a full-length TRPML1 C-terminally tagged with the small bioluminescent protein nanoluciferase. This ensures the correct localization of the ion channel in the lysosomal membrane and an optimal placement of the luciferase in the cytoplasm. We also developed a cell- and lysosome-permeable fluorescent BRET tracer that gives a BRET signal only when bound to the ion channel. This new protocol allows researchers worldwide to screen compounds that would interact with TRPML1 by using any plate reader with luminescent and fluorescence filters.
Homogeneous Time-Resolved Fluorescence-Based Assay to Screen ADP-Ribosyl Hydrolase Inhibitors
ADP ribosylation (ADPr) is a crucial post-translational modification that plays a vital role in DNA damage repair. Catalyzed by ADP ribose polymerases using NAD+ as a substrate, ADPr activates DNA repair pathways rapidly, thereby maintaining genomic integrity. The involvement of ADP ribose hydrolases in this process is significant, as they hydrolyze PAR chains, facilitating the release of ADPr-modified proteins from DNA or other proteins, which is essential for subsequent DNA repair steps. This protocol outlines a high-throughput screening method for identifying inhibitors of ADP ribose hydrolases, utilizing His-Tb-conjugated and ADPr-modified His-ADP ribose polymerase as the signal donor, and GST-d2-conjugated GST-XRCC1 as the signal receptor. The detection of time-resolved fluorescence signals enables efficient evaluation of compounds with potential therapeutic activity against cancer.